Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
This page is not indexed by search engines while we improve data quality.
Ct Hospitalier Universitaire Toulouse patents in 2026
Ct Hospitalier Universitaire Toulouse was listed as an assignee on 4 patent publications in 2026.
| Metric | Value |
|---|---|
| Company | Ct Hospitalier Universitaire Toulouse |
| Year | 2026 |
| Patents | 4 |
Patents
Representative publications for Ct Hospitalier Universitaire Toulouse in 2026.
Methods of diagnosing acute circulatory failure
US-2026086063-A1 · Mar 26, 2026 · US
Use of apelin for the treatment of lymphedema
US-2026041732-A1 · Feb 12, 2026 · US
Use of an annelid molecule for treating and/or preventing at least one complement-activation associated disease
US-2026035417-A1 · Feb 5, 2026 · US
Top CPC classifications
Most common classification codes for Ct Hospitalier Universitaire Toulouse in 2026.
| CPC | Patents |
|---|---|
| A61K35/62 | 1 |
| A61K35/76 | 1 |
| A61K38/00 | 1 |
| A61K38/1709 | 1 |
| A61K38/1796 | 1 |
Related pages
Navigate to parent entity pages.